Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.

Publication Type:

Journal Article

Source:

Alcoholism, clinical and experimental research, Volume 39, Issue 5, p.905-10 (2015)

Abstract:

Ethyl glucuronide (EtG) is an alcohol biomarker with potential utility as a clinical research and alcohol treatment outcome. Debate exists regarding the appropriate cutoff level for determining alcohol use, particularly with the EtG immunoassay. This study determined the EtG immunoassay cutoff levels that most closely correspond to self-reported drinking in alcohol-dependent outpatients.